COVID-19 disease outcomes in patients receiving clozapine versus other antipsychotics: a national study in Qatar

BackgroundClozapine has immunomodulatory effects that raised concerns about its potential to exacerbate severe COVID-19. This study examines whether clozapine use is associated with worse COVID-19 outcomes in patients with schizophrenia.MethodsThis retrospective cohort study compared COVID-19 outcom...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Dalia Albahari, Oraib Abdalla, Shatha Mahmud Ismail Alqam, Mohammed Faisal Hamad Mohammed, Mohamed Ali Siddig Ahmed, Ovais Wadoo
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2025-05-01
Edice:	Frontiers in Psychiatry
Témata:	Clozapine COVID-19 Schizophrenia SARS-CoV-2 antipsychotic agents hospitalization
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1527378/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!